Skip to main navigation
Skip to search
Skip to main content
UNT Health Home
Search content at UNT Health
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Design principles of drug combinations for chemotherapy
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Design principles of drug combinations for chemotherapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
5-flurouracil
14%
Breast Cancer Model
14%
Breast Cancer Treatment
14%
Cancer Drugs
14%
Cancer Treatment
14%
Cellular Assay
14%
Chemotherapy
100%
Clinical Option
14%
Combination Chemotherapy
14%
Combination Index
14%
Design Principles
100%
Dose-response
14%
Doxil
14%
Doxorubicin
14%
Drug Action
14%
Drug Combination
100%
Drug Cytotoxicity
14%
Drug Interactions
14%
Drug Pair
28%
Drug Pharmacokinetics
28%
Gemcitabine
71%
Highly Aggressive
14%
Hill Coefficient
28%
Hill Equation
14%
IC50
14%
Immune Response
14%
Immunogenic Cell Death
14%
In Vitro Parameters
14%
In Vivo Efficacy
14%
Inducing Agents
14%
Irinotecan
14%
Liposomal Encapsulation
14%
Liposomes
14%
Long-term Survival
14%
M2 Macrophages
14%
Median Survival Time
14%
Murine Breast Cancer
14%
Pegylated Liposomal Doxorubicin
100%
Prodrug
14%
Survival Study
14%
Synergistic Drug Combination
14%
Pharmacology, Toxicology and Pharmaceutical Science
Antiinfective Agent
12%
Breast Cancer
25%
Cancer Model
12%
Chemotherapy
100%
Combination Drug
100%
Doxorubicin
100%
Drug Cytotoxicity
12%
Drug Interaction
12%
Gemcitabine
62%
IC50
12%
Immunogenic Cell Death
12%
Irinotecan
12%
Liposome
87%
Long Term Survival
12%
Malignant Neoplasm
25%
Median Survival Time
12%
Pharmacokinetics
25%
Prodrug
12%